May 7, 2020 Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeuti...
Helping Create
Life Science Success Stories
SBI invests in exceptional VC-backed life science companies with their feet on the ground and their heads in the stars
Our portfolio
Investing in the most exciting technologies
Cures for serious, early-onset rare diseases by combining the best of gene therapy and gene editing
With a track record of over 1,200 investments, we are committed to Israel through our local office, SBIJI Innovation. We have already invested in top-tier biotech startups with disruptive technologies.
We strive to create an ecosystem that serves as a bridge between Israel and Asia.
Recent News
Feb 4, 2020 The EnforceAir is the U.S. DIU's core RF system for integration into a C-UAS system Read more
January 10, 2020 LogicBio Therapeutics Announces Submission of Investigational New Drug Application (IND) for LB-001 for Methylmalonic Acidemia (MMA) and Hig...